ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "population studies"

  • Abstract Number: 0161 • ACR Convergence 2024

    Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022

    malay rathod1, Eva Kalra2, Rafael Sanchez-Dopazo,3, Janmay Vala4, Saif Syed5, Akhilesh Sharma6, Ashwinikumar Shandilya7, Asmita Gera8, Mohit Lakkimsetti9, Juhi Patel10, VISHRANT AMIN11 and Hardik Desai12, 1Monmouth Medical Center, Rutgers University, Ewing, NJ, 2Trident Medical Cente, Charleston, SC, 3Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 6Adesh Institute of Medical Sciences and Research, Bhatinda, India, 7Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 8Tianjin medical University, Tianjin, China, Tianjin, Tianjin, China (People's Republic), 9Mamata Medical College,Khammam, Khammam, Telangana, India, 10GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 11GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 12Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) poses a significant and escalating health challenge across Latin America and the Caribbean (LAC), driven by demographic shifts, lifestyle factors, and varying…
  • Abstract Number: 2520 • ACR Convergence 2024

    Prevalence and Incidence of Giant Cell Arteritis Among Medicare Fee-For-Service Beneficiaries: United States, 2014–2019

    Peter Merkel1, Yi Peng2, Patrick Zueger2, Clara Ziadeh3, Ana B. Romero4, Richard Thielen3 and Denise Kruzikas3, 1Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 2AbbVie Inc, North Chicago, IL, 3AbbVie Inc., North Chicago, IL, 4AbbVie, North Chicago, IL

    Background/Purpose: Giant cell arteritis (GCA) is a vasculitis affecting individuals aged ≥50 years. Over 80% of patients with GCA are aged ≥70 years, reflecting a…
  • Abstract Number: 0365 • ACR Convergence 2024

    Patients’ Behaviors and Beliefs Around Dietary Changes Among a Cohort of Patients with Rheumatic Disease

    Aaron Stubbs, Deeba Minhas, Anne Arewasikporn and Andrew Schrepf, University of Michigan, Ann Arbor, MI

    Background/Purpose: Dietary interventions may help manage inflammation and are considered for adjunctive treatment of rheumatic diseases.  Our study aimed to explore patients' behaviors and beliefs…
  • Abstract Number: 2673 • ACR Convergence 2024

    Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis

    Diane Lacaille1, Coraline Danieli2, Kasra Moolooghy1 and Michal Abrahamowicz3, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2Research Institute of McGill University Health Center (RI-MUHC), Montreal, QC, Canada, 3McGill University, Verdun, Canada

    Background/Purpose: Glucocorticosteroid (GC) use is associated with increased mortality risk, especially from cardiovascular diseases (CVD) and infections, with dose and duration of use influencing risk.…
  • Abstract Number: 0735 • ACR Convergence 2024

    ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study

    Sebastian Klapa1, Henry Nording2, Marlene Ludwig3, Sabrina Arnold4, Khalaf Kridin5, Anja Staehle6, Ralf Ludwig7 and Peter Lamprecht4, 1University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, 2University of Lübeck, Cardioimmunology Research Group, Lübeck, Germany, 3Independent Researcher, Groß Grönau, Germany, 4University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, Germany, 55. Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel, 6University of Lübeck, Department of Rheumatology and Immunology, Lübeck, Germany, 7University of Lübeck, Lübeck Institute of Experimental Dermatology, Lübeck, Germany

    Background/Purpose: In spite of significantly improved therapy during the last years, long-term morbidity and mortality has remained high in ANCA-associated vasculitis (AAV). The main causes…
  • Abstract Number: 0997 • ACR Convergence 2024

    Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus

    Zoe Reed1, Janis Campbell2, Xana Howard1, Teresa Aberle1, Bridget Parrish1, Wade DeJager3, Cristina Arriens1, Joan Merrill4 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) has a complex etiology with genetic predispositions interacting with environmental factors. Extensive environmental exposure information is now publicly available based…
  • Abstract Number: 1223 • ACR Convergence 2024

    Community Based Study of Prevalence and Social Factors for Chronic Pain and Fibromyalgia in Women from Western India

    Vidit Gupta1, Diksha Mishra1, Shikhar Singh1, Vaishnavi Chowhan1, Shraddha Thorat1, Kavita Krishna2 and Sandeep Kansurkar3, 1Bharati Vidyapeeth (Deemed to be University) Medical College, Pune), Pune, Maharashtra, India, 2Bharati Vidyapeeth University Medical College and Hospital, Pune, Maharashtra, India, 3Bharati Vidyapeeth University Medical College, Pune, India

    Background/Purpose: Fibromyalgia is a disorder of chronic widespread pain. There is huge burden of this entity in community but there is scarcity of quality studies…
  • Abstract Number: 1299 • ACR Convergence 2024

    Board-Style Rheumatology Teaching for Medicine Residents: Novel Approach to Curriculum Development

    Merve Aksoy*, Shadi Jafari-Esfahani*, Yasaman Ahmadzadeh and Katarzyna Gilek-Seibert, Roger Williams Medical Center, Providence, RI

    Background/Purpose: During their training, internal medicine (IM) residents often have limited exposure to rheumatology, resulting in decreased confidence levels and inadequate scores on the In-training…
  • Abstract Number: 1485 • ACR Convergence 2024

    Genetic Contributions to Systemic Lupus Erythematosus: Concordance Rates in California Twins

    Rashmi Dhital1, Jia Yin Wan2, Kenneth Kalunian3 and Wendy Cozen4, 1UC San Diego, Brentwood, TN, 2Samueli School of Public Health, University of California Irvine, Irvine, CA, 3University of California San Diego, La Jolla, CA, 4University of California Irvine, Irvine

    Background/Purpose: Systemic lupus erythematosus (SLE) is influenced by both genetic and environmental factors. Twin studies in SLE have shown varying levels of concordance. This study…
  • Abstract Number: 1716 • ACR Convergence 2024

    Comparing the Risk of Severe Infections Associated with Different Classes of Biologic or Targeted Synthetic Agents for Inflammatory Arthritis: A Population-based Study

    Kasra Moolooghy1, Hui Xie2, Yufei Zheng3, J. Antonio Avina-Zubieta1 and Diane Lacaille1, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Simon Fraser University, Vancouver, BC, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada

    Background/Purpose: Various classes of biologic and targeted synthetic DMARDs (b/tsDMARDs) are now available for treatment of inflammatory arthritis (IA), but little information on their relative…
  • Abstract Number: 1873 • ACR Convergence 2024

    Race/Ethnicity and Household Income at the County Level Interacts with the Association of Urbanicity and Lupus Nephritis Mortality

    Snehin Rajkumar1, Eric Yen2 and Ram Singh3, 1UCLA David Geffen School of Medicine, Irvine, CA, 2UCLA, Los Angeles, CA, 3UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: The reasons underlying substantial variation in lupus nephritis (LN) deaths by race/ethnicity remain largely unknown. There are no large population-based studies focused on the…
  • Abstract Number: 1879 • ACR Convergence 2024

    Prevalence of Relapsing Polychondritis in Colombia: Data from the National Health Registry 2018 – 2023

    Mario Bautista-Vargas1, Adrian Romero-Ocampo2, Juan José Pino Vélez3, juliana Muñoz-Bedoya4 and Diego Rosselli5, 1Mayo Clinic, Rochester, Minnesota, USA., Rochester, MN, 2Universidad de Antioquia, Medellín – Colombia, Medellin, Antioquia, Colombia, 3Universidad de Antioquia, Envigado, Antioquia, Colombia, 4Universidad Corpas, Bogotá, Colombia, 5Pontificia Universidad Javeriana, Bogotá, Colombia

    Background/Purpose: The implementation of the SISPRO system enables it to function as a tool capable of collecting pertinent health system data. This information is publicly…
  • Abstract Number: 1882 • ACR Convergence 2024

    30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database

    Shobhit Piplani1, Priyanshu Jain2, Vladimir Jelic3, Clement Tagoe4 and Beverly Johnson5, 1Jacobi Medical Center/North Central Bronx Albert Einstein College of Medicine NYC Health and Hospitals, Bronx, NY, 2Jawaharlal Nehru Medical College, Belgaum, Karnataka, India, Bronx, NY, 3Jacobi Medical Center/North Central Bronx, Bronx, NY, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY, 5Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Rheumatoid Arthirits (RA) is associated with heightened morbidity, diminished quality of life, and increased healthcare expenses. This research aims to bridge this gap by…
  • Abstract Number: 1896 • ACR Convergence 2024

    The Prevalence, Incidence, Risk Factors and Time to Diagnosis of Behcet’s Syndrome in England: A Retrospective Nested Case Control Study in Clinical Practice Research Datalink and Hospital Episode Statistics

    Priyanka Chandratre1, Joht Chandan2, Ben Hammond3, Rasiah Thayakaran3, Samuel Cusworth3, Nicola Adderley3 and Deva Situnayake4, 1The Ottawa Hospital and Ottawa Hospital Research Institute (OHRI), Ottawa, ON, Canada, 2Institute of Applied Health Research, Birmingham, United Kingdom, 3Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom, 4Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom

    Background/Purpose: The prevalence and incidence of Behcet’s syndrome (BS) in the UK is unknown at an unselected population level. BS may be associated with phenotypically…
  • Abstract Number: 0137 • ACR Convergence 2024

    The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR

    Tahmina Begum1, Bhagyavalli Veeranki1, Ogenna Chike1 and Titilola Falasinnu2, 1Stanford School of Medicine, Stanford, 2Stanford School of Medicine, Palo Alto, CA

    Background/Purpose: To create greater precision in case definitions for chronic pain in EHRs, we recently identified 15 different case definitions for chronic pain using structured…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology